SDRC investigators find evidence in CREDENCE clinical trial for efficacy and safety of canagliflozin for type2 diabetes

Previous
Previous

SDRC investigators team up to create a new device that can perform blood tests continually

Next
Next

Carolyn Bertozzi named Baker Family Director of Stanford ChEM-H